BioGPS
  • Home
  • Help
  • Plugins
  • Datasets
  • Sign Up
  • Login
Examples: Gene Symbol(s), Gene Ontology, Splicing plugins, Melanoma datasets
advanced
Home › Dataset Library › Genomic Grade Index (GGI): Feasibility in routine practice and impact on treatment decisions in early breast cancer

Dataset: Genomic Grade Index (GGI): Feasibility in routine practice and impact on treatment decisions in early breast cancer

Genomic Grade Index (GGI) is a 97-gene signature that improves histologic grade (HG) classification in invasive breast carcinoma. In this...

Registered by ArrayExpress Uploader
View Dataset

Genomic Grade Index (GGI) is a 97-gene signature that improves histologic grade (HG) classification in invasive breast carcinoma. In this prospective study we sought to evaluate the feasibility of performing GGI in routine clinical practice and its impact on treatment recommendations. Patients with pT1pT2 or operable pT3, N0-3 invasive breast carcinoma were recruited from 8 centers in Belgium. Fresh surgical samples were sent at room temperature in the MapQuant Dx™ PathKit for centralized genomic analysis. Genomic profiles were determined using Affymetrix U133 Plus 2.0 and GGI calculated using the MapQuant Dx™ protocol, which defines tumors as low or high Genomic Grade (GG-1 and GG-3 respectively). 180 pts were recruited and 155 were eligible. The MapQuant test was performed in 142 cases and GGI was obtained in 78% of cases (n=111). Reasons for failures were 15 samples with <30% of invasive tumor cells (11%), 15 with insufficient RNA quality (10%), and 1 failed hybridization (<1%). For tumors with an available representative sample (≥ 30% inv. tumor cells) (n=127), the success rate was 87.5 %. GGI reclassified 69% of the 54 HG2 tumors as GG-1 (54%) or GG-3 (46%). Changes in treatment recommendations occurred mainly in the subset of HG2 tumors reclassified into GG-3, with increased use of chemotherapy in this subset. The use of GGI is feasible in routine clinical practice and impacts treatment decisions in early-stage breast cancer. Total RNA was extracted from fresh tumor tissues comprising ≥30% invasive tumor cells and hybridized on Affymetrix microarrays if the RIN was ≥ 7.

Species:
human

Samples:
111

Source:
E-GEOD-43365

Updated:
Dec.12, 2014

Registered:
Jul.12, 2014


Factors: (via ArrayExpress)
Sample PR SIZE MM CENTRE COMORB GRADE HISTO AGE GG HIST MENOP HER2 NODES GGI ER
GSM1061142 1 15 1 average for age 2 80 equivocal lobular postmenopausal 0 0 -0.3 1
GSM106114 1 10 1 minor 1 75 equivocal ductal postmenopausal 0 0 0.2 1
GSM1061140 0 17 1 minor 3 42 3 ductal premenopausal 0 0 2 1
GSM1061139 1 11 1 minor 1 51 1 ductal postmenopausal 0 0 -1.5 1
GSM1061138 1 16 1 minor 3 41 3 ductal NA 1 0 0.6 1
GSM1061137 0 28 6 perfect health 3 48 3 ductal premenopausal 0 0 3.1 1
GSM1061136 1 8 6 perfect health 3 60 3 ductal postmenopausal 1 0 0.5 1
GSM1061135 0 12 6 perfect health 1 56 1 ductal NA 0 0 -0.6 1
GSM1061134 0 45 6 major problems 2 78 3 ductal postmenopausal 0 1 0.4 1
GSM1061133 1 12 6 perfect health 2 43 1 ductal premenopausal 0 0 -0.7 1
GSM1061132 1 42 6 perfect health 2 69 3 ductal NA 0 2 1.4 1
GSM106113 0 18 6 perfect health 2 53 1 ductal NA 0 0 -0.6 1
GSM1061130 1 32 6 perfect health 3 54 1 lobular postmenopausal 1 0 -0.7 1
GSM1061129 1 35 6 major problems 2 63 1 ductal NA 0 0 -1.1 1
GSM1061128 0 17 6 perfect health 3 38 3 ductal premenopausal 0 0 2.4 0
GSM1061127 1 45 6 major problems 3 70 3 ductal postmenopausal 0 1 1.6 1
GSM1061126 1 8 3 minor 2 53 1 lobular postmenopausal 0 0 -1.2 1
GSM1061125 1 15 3 minor 2 62 equivocal ductal postmenopausal 0 0 -0.3 1
GSM1061124 1 18 3 minor 2 58 equivocal ductal postmenopausal 0 1 0.1 1
GSM1061123 1 12 3 minor 1 51 1 ductal postmenopausal 0 0 -1 1
GSM1061122 1 13 1 minor 2 43 equivocal ductal premenopausal 0 0 -0.1 1
GSM106112 1 20 6 minor 1 56 1 lobular postmenopausal 0 0 -1 1
GSM1061120 0 13 6 perfect health 3 45 3 ductal premenopausal 0 1 1.2 1
GSM1061119 1 6 6 major problems 2 64 1 ductal postmenopausal 0 0 -1.9 1
GSM1061118 0 45 6 major problems 3 87 3 ductal postmenopausal 1 0 1.9 0
GSM1061117 1 13 6 minor 2 51 1 ductal NA 0 1 -0.4 1
GSM1061116 1 30 6 minor 2 67 1 lobular postmenopausal 0 0 -2.3 1
GSM1061115 1 13 6 average for age 1 84 1 ductal postmenopausal 0 0 -0.8 1
GSM1061114 0 9 9 perfect health 2 56 3 ductal postmenopausal 0 0 0.8 0
GSM1061113 0 33 9 perfect health 3 47 3 ductal premenopausal 0 0 3.3 0
GSM1061112 1 17 9 perfect health 1 78 1 ductal postmenopausal 0 0 -0.5 1
GSM106 0 30 6 NA 3 76 3 ductal postmenopausal 1 2 1.6 0
GSM1061110 1 15 6 major problems 2 53 equivocal ductal NA 0 0 -0.1 1
GSM1061109 1 12 6 major problems 1 52 1 lobular premenopausal 0 0 -2.3 1
GSM1061108 1 16 6 minor 2 47 1 ductal NA 0 0 -1.5 1
GSM1061107 1 15 6 major problems 1 49 3 ductal premenopausal 0 0 1 1
GSM1061106 1 15 6 perfect health 2 58 3 ductal NA NA 0 0.7 1
GSM1061105 1 22 6 minor 3 77 3 ductal postmenopausal 0 3 1.3 1
GSM1061104 0 9 6 minor 2 60 equivocal ductal postmenopausal 0 0 0.1 1
GSM1061103 0 25 6 average for age 2 75 3 ductal postmenopausal 0 2 0.9 1
GSM1061102 1 18 6 minor 3 63 3 ductal NA 1 1 0.8 1
GSM106110 1 15 6 perfect health 2 66 1 ductal postmenopausal 0 0 -0.6 1
GSM1061100 0 15 6 perfect health 3 49 3 ductal premenopausal 1 2 0.8 0
GSM1061099 1 20 9 perfect health 2 47 3 ductal premenopausal 0 0 0.4 1
GSM1061098 1 17 9 perfect health 2 55 3 ductal postmenopausal 0 0 2 1
GSM1061097 0 26 9 perfect health 2 44 3 ductal premenopausal 0 0 0.7 1
GSM1061096 1 13 9 perfect health 2 64 1 ductal postmenopausal 0 0 -1 1
GSM1061095 0 32 9 perfect health 2 64 3 ductal postmenopausal 0 1 0.4 1
GSM1061094 1 21 9 perfect health 1 49 1 ductal premenopausal 0 0 -0.6 1
GSM1061093 1 15 9 perfect health 2 44 1 ductal premenopausal 0 0 -0.6 1
GSM1061092 1 25 9 perfect health 2 44 3 ductal premenopausal 0 0 1.1 1
GSM106109 1 17 9 perfect health 2 42 1 lobular premenopausal 0 0 -1.2 1
GSM1061090 0 23 9 perfect health 3 31 3 ductal premenopausal 0 0 2.8 0
GSM1061089 1 19 9 perfect health 2 53 equivocal ductal premenopausal 0 0 -0.1 1
GSM1061088 0 27 9 average for age 3 82 1 lobular postmenopausal 0 0 -0.3 0
GSM1061087 1 12 9 perfect health 1 64 1 ductal postmenopausal 0 0 -0.8 1
GSM1061086 1 15 9 perfect health 2 61 1 ductal postmenopausal 0 0 -0.4 1
GSM1061085 0 22 9 perfect health 3 73 3 lobular postmenopausal 0 0 0.4 1
GSM1061084 0 22 9 average for age 3 82 3 ductal postmenopausal 1 0 0.4 0
GSM1061083 1 11 9 perfect health 2 65 1 ductal postmenopausal 0 1 -2.2 1
GSM1061082 0 22 9 perfect health 3 35 3 ductal premenopausal 0 1 2.9 1
GSM106108 1 25 2 perfect health 2 61 equivocal ductal postmenopausal 0 1 -0.1 1
GSM1061080 1 10 2 minor 1 48 1 ductal premenopausal 0 0 -2.5 1
GSM1061079 1 30 2 minor 2 58 equivocal ductal postmenopausal 0 1 0.2 1
GSM1061078 1 17 2 minor 2 47 equivocal ductal premenopausal 0 0 -0.1 1
GSM1061077 1 42 1 minor 3 71 equivocal ductal postmenopausal 0 0 0.1 1
GSM1061076 0 12 1 average for age 2 71 equivocal ductal postmenopausal 0 0 -0.1 0
GSM1061075 1 42 1 average for age 3 78 3 ductal postmenopausal 1 0 0.6 1
GSM1061074 1 15 1 minor 2 49 equivocal ductal premenopausal 0 0 -0.2 1
GSM1061073 1 12 1 average for age 3 55 3 ductal postmenopausal 0 0 1.3 1
GSM1061072 1 40 1 average for age 3 73 3 ductal postmenopausal 0 3 1.5 1
GSM106107 1 41 1 perfect health 1 42 1 ductal premenopausal 0 0 -0.8 1
GSM1061070 1 14 1 major problems 1 81 equivocal ductal postmenopausal 0 0 -0.2 1
GSM1061069 1 17 6 minor 3 42 equivocal ductal premenopausal 0 0 0.2 1
GSM1061068 1 19 6 average for age 1 78 equivocal lobular postmenopausal 0 0 -0.3 1
GSM1061067 1 21 6 perfect health 3 53 3 ductal premenopausal 0 1 0.4 1
GSM1061066 0 15 9 perfect health 2 50 1 ductal postmenopausal 1 0 -0.3 1
GSM1061065 0 13 9 perfect health 2 39 3 ductal premenopausal 0 0 2.4 0
GSM1061064 1 28 9 perfect health 2 53 equivocal lobular postmenopausal 0 3 -0.2 1
GSM1061063 1 28 9 perfect health 3 41 3 ductal premenopausal 0 1 1.5 1
GSM1061062 0 32 9 perfect health 3 46 3 ductal premenopausal 0 0 3.1 0
GSM106106 0 9 3 minor 1 66 1 ductal postmenopausal 0 0 -2 1
GSM1061060 0 21 3 major problems 3 69 3 ductal postmenopausal 0 0 3.1 0
GSM1061059 1 24 3 major problems 2 60 3 ductal postmenopausal 0 0 0.6 1
GSM1061058 1 35 3 minor 3 54 3 lobular postmenopausal 0 0 0.9 1
GSM1061057 1 19 3 NA 3 71 3 ductal postmenopausal 0 0 1.5 1
GSM1061056 1 24 3 average for age 1 76 equivocal ductal postmenopausal 0 0 -0.2 1
GSM1061055 1 18 3 perfect health 1 78 equivocal ductal postmenopausal 0 0 -0.3 1
GSM1061054 1 44 8 perfect health 3 73 1 ductal postmenopausal 0 3 -0.6 1
GSM1061053 0 11 2 minor 3 48 3 ductal premenopausal 0 0 1.2 0
GSM1061052 1 16 2 minor 2 56 equivocal ductal postmenopausal 1 2 0.3 1
GSM106105 1 11 2 minor 2 77 1 ductal postmenopausal 0 1 -1 1
GSM1061050 1 28 2 minor 2 51 1 ductal premenopausal 0 1 -1.5 1
GSM1061049 1 18 2 minor 1 67 1 ductal postmenopausal 0 0 -2.3 1
GSM1061048 1 10 2 perfect health 2 48 equivocal ductal premenopausal 0 0 0 1
GSM1061047 1 18 6 perfect health 3 67 1 ductal postmenopausal 0 1 -0.4 1
GSM1061046 0 50 6 perfect health 2 66 3 ductal postmenopausal 0 0 0.7 1
GSM1061045 1 11 6 minor 1 72 1 ductal postmenopausal 0 3 -1.8 1
GSM1061044 1 12 6 perfect health 2 53 1 ductal NA 0 0 -1.3 1
GSM1061043 0 45 6 minor 3 54 3 ductal postmenopausal 1 0 1.5 0
GSM1061042 0 10 6 perfect health 2 61 3 ductal postmenopausal 0 0 0.6 1
GSM106104 1 15 1 major problems 2 81 equivocal lobular postmenopausal 0 0 0.1 1
GSM1061040 1 13 1 minor 2 47 equivocal ductal premenopausal 0 0 0 1
GSM1061039 0 18 1 NA 3 90 3 ductal postmenopausal NA 0 0.4 0
GSM1061038 1 11 1 minor 2 61 1 lobular postmenopausal 0 0 -0.8 1
GSM1061037 1 16 1 average for age 1 76 1 lobular postmenopausal 0 0 -2.2 1
GSM1061036 0 19 1 perfect health 3 43 3 ductal NA 0 0 2.5 0
GSM1061035 1 30 1 average for age 2 65 1 ductal postmenopausal 0 0 -0.6 1
GSM1061034 0 10 4 average for age 2 59 3 ductal postmenopausal 1 0 0.5 0
GSM1061033 1 22 4 major problems 2 60 3 ductal postmenopausal 0 0 2.2 1
GSM1061032 1 17 6 perfect health 2 68 3 ductal postmenopausal 0 0 0.7 1

Tags

  • breast
  • breast cancer
  • breast carcinoma
  • cancer
  • carcinoma

Other Formats

JSON    XML
  • About
  • Blog
  • Help
  • FAQ
  • Downloads
  • API
  • iPhone App
  • Email updates
© 2026 The Scripps Research Institute. All rights reserved. (ver 94eefe6 )
  • Terms of Use